Fluorescence imaging of blood–brain barrier disruption

[1]  R. Egleton,et al.  Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. , 2005, American journal of physiology. Heart and circulatory physiology.

[2]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[3]  Q. Pittman,et al.  Disruption of the blood–brain barrier during TNBS colitis , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[4]  J. Pachter,et al.  Where is the blood–brain barrier … really? , 2005, Journal of neuroscience research.

[5]  R. Egleton,et al.  Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution , 2004, Brain Research.

[6]  R. Egleton,et al.  Mannitol opening of the blood–brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin , 2004, Brain Research.

[7]  Tetsuro Takamatsu,et al.  Regional differences in blood–nerve barrier function and tight-junction protein expression within the rat dorsal root ganglion , 2004, Neuroreport.

[8]  T. Davis,et al.  Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. , 2003, American journal of physiology. Heart and circulatory physiology.

[9]  R. Mumper,et al.  Evaluation of blood–brain barrier thiamine efflux using the in situ rat brain perfusion method , 2003, Journal of neurochemistry.

[10]  A. Andersen,et al.  Cerebrovascular changes in the basal ganglia with HIV dementia , 2000, Neurology.

[11]  D. Miller,et al.  Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. , 1998, Biochemical and biophysical research communications.

[12]  E. Preston,et al.  Evidence for pore-like opening of the blood-brain barrier following forebrain ischemia in rats , 1997, Brain Research.

[13]  F. Joó,et al.  Intracarotid tumor necrosis factor-α administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis , 1996, Neuroscience Letters.

[14]  J. Preston,et al.  Permeability of the developing blood-brain barrier to 14C-mannitol using the rat in situ brain perfusion technique. , 1995, Brain research. Developmental brain research.

[15]  W. Pardridge,et al.  Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins , 1990, Journal of neurochemistry.

[16]  S. Hatashita,et al.  Brain edema and cerebrovascular permeability during cerebral ischemia in rats. , 1990, Stroke.

[17]  D. Begley,et al.  Measurement of Solute Transport Across the Blood–Brain Barrier in the Perfused Guinea Pig Brain: Method and Application to N‐Methyl‐α‐Aminoisobutyric Acid , 1986, Journal of neurochemistry.

[18]  C. Nitsch,et al.  Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents , 1983, Journal of the Neurological Sciences.

[19]  B. Johansson.  Cerebral air embolism and the blood‐brain barrier in the rat , 1980, Acta neurologica Scandinavica.

[20]  T. Tervo,et al.  Penetration barrier to sodium fluorescein and fluorescein-labelled dextrans of various molecular sizes in brain capillaries , 1979, Experientia.

[21]  H. Hoffman,et al.  Spread of sodium fluorescein in normal brain tissue , 1961, Neurology.

[22]  M. Gregersen,et al.  Spectral absorption of T-1824 in plasma of various species and recovery of the dye by extraction. , 1953, The American journal of physiology.

[23]  E. B. Reeve,et al.  Observations on the estimate of the circulating red blood cell volume in man given by T 1824 and the haematocrit, with special reference to uncorrected dye loss from the circulation. , 1948, Clinical science.

[24]  Donald W. Miller,et al.  Effect of Probenecid on Fluorescein Transport in the Central Nervous System Using In Vitro and In Vivo Models , 2004, Pharmaceutical Research.

[25]  M. Wolman,et al.  Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier , 2004, Acta Neuropathologica.

[26]  Q. Smith,et al.  A review of blood-brain barrier transport techniques. , 2003, Methods in molecular medicine.

[27]  S. Nag,et al.  Blood-brain barrier permeability using tracers and immunohistochemistry. , 2003, Methods in molecular medicine.